欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Cancer

货号 产品名 CAS号 信息
CSN19165 (E)-1-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one hydrochloride 521984-48-5 SIS3 is an inhibitor of Smad3 and can inhibit TGF-β and activin signaling without affecting other pathways.
CSN19147 LY 303511 HCl 2070014-90-1 LY303511 HCl is an analogue of LY294002 which can inhibit mTOR-dependent phosphorylation of S6K, but not PI3K-dependent phosphorylation of Akt. It also blocks voltage-gated potassium (Kv) channels with IC50 value of 64.6 μM.
CSN19151 BFH772 890128-81-1 BFH772 selectively targets VEGFR2 kinase with IC50 of 3 nM.
CSN19180 CX-6258 HCl 1353859-00-3 CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.
CSN19182 Cilengitide TFA 199807-35-7 Cilengitide Trifluoroacetate is a cyclic RGD pentapeptide antagonist of integrins αvβ3, αvβ5 and α5β1.
CSN19198 INH6 1001753-24-7 INH6 can bind to Hec1 and inhibit its association with Nek2 and kinetochores.
CSN19201 N-((1R,2S)-2-Phenylcyclopropyl)piperidin-4-amine dihydrochloride 1821798-25-7 GSK-LSD1 2HCl is a selective LSD1 inhibitor with IC50 of 16 nM.
CSN19204 Cerdulatinib HCl 1369761-01-2 Cerdulatinib HCl is a dual JAK/SYK inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. It also inhibits other kinases with IC50 less than 200 nM.
CSN19214 Cyclo(-RGDfK) TFA 500577-51-5 Cyclo(-RGDfK) Trifluoroacetate is a highly potent and selective inhibitor for the αvβ3 integrin with a IC50 of 0.94 nM.
CSN19142 CZ415 1429639-50-8 CZ415 is a potent and highly selective ATP-competitive mTOR inhibitor with pKdapp value of 8.2.
CSN19162 Ciliobrevin A 302803-72-1 Ciliobrevin A inhibits hedgehog (Hh) signaling pathway with IC50 less than 10 μM.
CSN19222 Chetomin 1403-36-7 Chetomin is an inhibitor of HIF-1 by weaken transcription of HIF-1,disrupting the binding of HIF-1α and HIF-2α to p300 at low nanomolar concentrations.
CSN19229 Chaetocin 28097-03-2 Chaetocin, a natural product from Chaetomium species, is a histone methyltransferase inhibitor with IC50 of 0.8 μM, 2.5 μM and 3 μM for dSU (VAR)3-9, mouse G9a and Neurospora crassa DIM5, respectively. It also inhibits thioredoxin reductase (TrxR) with an IC50 of 4 μM.
CSN19243 6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile hydrochloride 2095432-28-1 CPI-455 HCl is an inhibitor of KDM5. It can elevate global levels of H3K4 trimethylation (H3K4me3) and decrease the number of DTPs in multiple cancer cell line models.
CSN19234 PD0166285 185039-89-8 PD0166285 inhibits Wee1 and Chk1 at nanomolar concentrations and can hinder G2 checkpoint.
CSN19153 S49076 1265965-22-7 S49076 is a potent inhibitor of MET, AXL/MER, and FGFRs.
CSN19228 Sabutoclax 1228108-65-3 Sabutoclax is a pan-Bcl-2 inhibitor, including Bcl-xL, Bcl-2, Mcl-1 and Bfl-1 with IC50 of 0.31 μM, 0.32 μM, 0.20 μM and 0.62 μM, respectively.
CSN19209 PRT060318 Dihydrochloride N/A PRT060318 2HCl is a selective inhibitor of the Syk tyrosine kinase, as an approach to HIT treatment.
CSN19192 PF-562271 HCl 939791-41-0 PF-562271 HCl is the HCl salt of PF-562271, which is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and > 100-fold selectivity against other protein kinases, except for some CDKs.
CSN19183 SANT-1 304909-07-7 SANT-1 can directly bind to Smoothened (Smo) receptor with Kd of 1.2 nM. It also exhibits inhibition of Smo agonist effects (IC50 = 20 nM).
CSN19149 Laduviglusib 3HCl 1782235-14-6 CHIR-99021 3HCl is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM, showing > 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases.
CSN19148 GSK2110183 analog 1 HCl 2070009-64-0 GSK2110183 HCl is an orally bioavailable, selective, ATP-competitive and potent pan-Akt inhibitor with IC50s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.
CSN19154 Ibrutinib-biotin 1599432-18-4 Ibrutinib-biotin is a probe that consists of Ibrutinib linked to biotin via a long chain linker, with an IC50 of 0.755-1.02 nM for BTK.
CSN19143 PQR620 1927857-56-4 PRQ620 is a highly potent and selective mTORC1/2 inhibitor, shows anti-tumor effects in vitro and in vivo.
CSN19155 Futibatinib 1448169-71-8 FGFR-IN-1 is a potent and highly selective FGFR inhibitor, used for antitumor treatment.
CSN19225 N-(3-((5-Cyclopropyl-2-((2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide hydrochloride(1:x) 2599216-02-9 MRT68921·xHCl is a potent and dual autophagy kinase ULK1/2 inhibitor with IC50 of 2.9 nM and 1.1 nM, respectively.
CSN19210 SAG HCl 2095432-58-7 SAG HCl is a cell-permeable Smoothened (Smo) agonist with EC50 of 3 nM in Shh-LIGHT2 cells.
CSN19145 A-674563 HCl 2070009-66-2 A-674563 HCl is a potent and selective Akt1 inhibitor with Ki of 11 nM.
CSN19156 UNC2025 HCl 2070015-17-5 UNC2025 HCl is a potent and orally bioavailable Mer/Flt3 dual inhibitor with IC50 of 0.8/0.74 nM for Mer/Flt3.
CSN19164 RU-SKI 43 HCl 1782573-67-4 RU-SKI 43 HCl is a small molecule inhibitor of Hhat (Hedgehog acyltransferase), the enzyme responsible for the attachment of palmitate onto Shh.
CSN19157 (Rac)-IBT6A hydrochloride 1807619-60-8 Btk inhibitor 1 HCl is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.
CSN19141 CAY10505 1218777-13-9 CAY10505 is dehydroxyl of AS-252424, which is a PI3Kγ inhibitor with IC50 of 33 nM.
CSN19158 CEP-28122 mesylate salt 1431697-88-9 CEP-28122 mesylate is a highly potent and selective orally active ALK inhibitor with IC50 of 1.9 ± 0.5 nM in an enzyme-based TRF assay.
CSN19211 GSK2879552 2HCl 1902123-72-1 GSK2879552 2HCl is an orally available, irreversible, inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
CSN19176 6-((2-((4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile monohydrochloride 1797989-42-4 CHIR-99021 HCl is HCl of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM and shows greater than 500-fold selectivity for GSK-3 versus its closest homologs Cdc2 and ERK2.
CSN19216 2-((4,6-Dimethylpyrimidin-2-yl)thio)-N-(5-(naphthalen-1-ylmethyl)thiazol-2-yl)acetamide 709002-46-0 SirReal2 is a potent and selective Sirt2 inhibitor with IC50 of 140 nM.
CSN19159 Fenebrutinib 1434048-34-6 GDC-0853 is a potent and orally BTK inhibitor.
CSN19188 K-Ras(G12C) inhibitor 9 1469337-91-4 K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras (G12C).
CSN19199 TAI-1 1334921-03-7 TAI-1 is a potent and specific Hec1 inhibitor, which disrupts Hec1-Nek2 protein interaction.
CSN19172 Dovitinib dilactic acid 852433-84-2 Dovitinib dilactic acid is the dilactic acid of dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2.
CSN19190 CH5138303 959763-06-5 CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
CSN19202 BV-6 Trifluoroacetate N/A BV-6 trifluoroacetate is a SMAC mimetic, dual cIAP and XIAP inhibitor.
CSN19221 GSK2292767 1254036-66-2 GSK2292767 is a potent and selective PI3Kδ inhibitor.
CSN19230 Z-VAD-FMK 161401-82-7 Z-VAD-FMK is an irreversible pan-caspase inhibitor.
CSN19191 ARQ 621 1095253-39-6 ARQ 621 is an allosteric, and selective Eg5 mitotic motor protein inhibitor.
CSN19241 SRT 2183 1001908-89-9 SRT2183 is a small-molecule activator of the sirtuin subtype SIRT1.
CSN19232 RHPS4 390362-78-4 RHPS4 is a potent inhibitor of Telomerase at submicromolar.
CSN19233 MS049 2HCl 2095432-59-8 MS049 2HCl is a potent and selective inhibitor of PRMT4 and PRMT6 with IC50s of 34 nM and 43 nM, respectively.
<< PREV 6 7 8 9 10 11 12 13 14 NEXT >>
联系
我们